Home
Search
Study Topics
Glossary
|
|
|
|
|
|
Sponsors and Collaborators: |
Aristotle University Of Thessaloniki Alcon Research |
---|---|
Information provided by: | Aristotle University Of Thessaloniki |
ClinicalTrials.gov Identifier: | NCT00757835 |
A crossover, randomized, single-masked study which compares the short-term (3 months) 24-hour IOP control and safety of travoprost/timolol fixed combination given once in the evening, versus that of latanoprost/timolol fixed combination given once in the evening in patients with exfoliative glaucoma. The primary objective of this trial is to compare the quality of 24-hour IOP control after 3 months of chronic therapy with these two medications.
Condition | Intervention | Phase |
---|---|---|
Glaucoma |
Drug: treatment with latanoprost/timolol fixed combination Drug: latanoprost/timolol fixed combination drops |
Phase IV |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Single Blind (Investigator), Active Control, Crossover Assignment, Safety/Efficacy Study |
Official Title: | 24-Hour IOP Control With the Travoprost/Timolol Fixed Combination Compared With the Latanoprost/Timolol Fixed Combination, When Both Are Dosed in the Evening in Patients With Exfoliative Glaucoma |
Enrollment: | 40 |
Study Start Date: | May 2008 |
Estimated Study Completion Date: | January 2009 |
Estimated Primary Completion Date: | January 2009 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
A: Active Comparator
treatment with travoprost/timolol fixed combination drops once in the evening
|
Drug: treatment with latanoprost/timolol fixed combination
dosing in the evening with the two fixed combinations
|
B: Active Comparator
Treatment with latanoprost/timolol fixed combination
|
Drug: latanoprost/timolol fixed combination drops
once in the evening
|
Ages Eligible for Study: | 21 Years to 85 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Responsible Party: | Glaucoma Unit, 1st University Department of Ophthalmology ( Associate Professor AGP Konstas ) |
Study ID Numbers: | A6219 |
Study First Received: | September 19, 2008 |
Last Updated: | November 7, 2008 |
ClinicalTrials.gov Identifier: | NCT00757835 |
Health Authority: | Greece: National Organization of Medicines |
24-hour IOP exfoliative glaucoma travoprost/timolol latanoprost/timolol fixed combinations |
Glaucoma Eye Diseases Timolol Latanoprost |
Travoprost Hypertension Ocular Hypertension |
Neurotransmitter Agents Molecular Mechanisms of Pharmacological Action Adrenergic Agents Therapeutic Uses Physiological Effects of Drugs Adrenergic beta-Antagonists |
Adrenergic Antagonists Cardiovascular Agents Anti-Arrhythmia Agents Antihypertensive Agents Pharmacologic Actions |